Deep-learning CADe colonoscopy raises adenoma detection in a double-blind trial
In a double-blind randomised trial of 962 patients in China (484 analysed with CADe, 478 with a sham system), the deep-learning system raised adenoma detection to 34% (165/484) from 28% (132/478), OR 1.36 (95% CI 1.03-1.79). The primary analysis was per protocol, the trial was single-centre, and the abstract reports no ITT analysis.
Technology: Deep-learning computer-aided detection (CADe) system for polyps during colonoscopy
Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: prospective or independent check
- Tested: A double-blind randomised trial of 962 patients compared colonoscopy with a deep-learning CADe system against a sham system; the primary outcome was adenoma detection rate, analysed per protocol (CADe 34% vs sham 28%).
- Still unknown: The trial is single-centre, the primary analysis is per protocol with no ITT analysis reported, and the effect on interval colorectal cancer still needs investigation.
- AI role: A deep-learning CADe system gave real-time visual alarms for possible polyps during colonoscopy.
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31981517%20AND%20SRC:MED&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 437 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 4/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.